SEC Form 4 · accession 0001193125-26-394803
Apollomics Inc. · APLM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Yi-Kuei Chen
Officer — Chief Operating Officer · Director
Period of report
Sep 14, 2026
Accepted (ET)
Sep 17, 2026 · 8:48 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001944885
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| CLASS A ORDINARY SHARES | Sep 15, 2026 | M | 5,000 | $0.00 | A | 20,100 | D | |
| CLASS A ORDINARY SHARESF1 | holding | — | — | — | 121,248 | I | Through Maxpro Investment Co., Ltd. |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $23.18 | Sep 14, 2026 | A | 8,000 | A | — | Sep 14, 2026 | CLASS A ORDINARY SHARES | 8,000 | 8,000 | D |
| Restricted Stock UnitsF3,F4 | — | Sep 15, 2026 | M | 5,000 | D | — | — | CLASS A ORDINARY SHARES | 5,000 | 5,000 | D |
Explanation of responses
- F1The reporting person is a member of the Board of Directors of Maxpro Investment Co., Ltd. and is co-founder and managing director of Maxpro Ventures Ltd. The amount reported includes a 100 share adjustment for shares previously owned but inadvertently omitted. Excludes 3,823 Class A Ordinary Shares issuable upon the exercise of warrants held directly by Maxpro Investment Co., Ltd., which were previously reported on the Form 3 filed March 18, 2026 and the Form 3/A filed April 14, 2026. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
- F2The stock option was granted under the Apollomics Inc. 2023 Incentive Award Plan on September 14, 2026. The option vests and becomes exercisable over a one-year period: fifty percent (50%) of the shares subject to the option vest on March 14, 2027 (six months from the grant date), and the remaining fifty percent (50%) vest on September 14, 2027 (twelve months from the grant date), subject to the reporting person's continued service to the Issuer through each applicable vesting date.
- F3Each restricted stock unit represents a contingent right to receive one Class A Ordinary Share
- F4RSUs were granted and previously reported on a Form 3 filed March 18, 2026 and a Form 3/A filed April 14, 2026. Of the initial RSU grant, 5,000 shares vested on each of February 9, 2026, March 15, 2026, June 15, 2026 and September 15, 2026. This transaction represents the vesting of 5,000 RSUs on September 15, 2026.